Synthesis, spectroscopic, and biological evaluation of some levofloxacin metal complexes

Najma Sultana1, M. Saeed Arayne2, Syeda Bushra Shakeb Rizvi2, Urooj Haroon3, M. Ahmed Mesaik4
1Department of Pharmaceutical Chemistry, Research Institute of Pharmaceutical Sciences, Faculty of Pharmacy, University of Karachi, Karachi, Pakistan
2Department of Chemistry, University of Karachi, Karachi, Pakistan
3Department of Chemistry, Federal Urdu University for Arts, Science and Technology, Karachi, Pakistan
4PCMD, International Centre of Chemical Sciences, University of Karachi, Karachi, Pakistan

Tóm tắt

Từ khóa


Tài liệu tham khảo

Anacona JR, Toledo C (2001) Synthesis and antibacterial activity of metal complexes of ciprofloxacin. Transition Met Chem 26:228–231

Arayne MS, Sultana N, Haroon U, Mesaik MA (2009) Synthesis, characterization, antibacterial and anti-inflammatory activities of enoxacin metal complexes. Bioinorg Chem Appl 2009:914105

Bauer AW, Kirby WMM, Sherris JC, Turck M (1966) Antibiotic susceptibility testing by a standard single disk method. Am J Clin Pathol 45:493–496

Chattah AK, Linck YG, Monti GA, Levstein PR, Breda SA, Manzo RH, Olivera ME (2007) NMR and IR characterization of the aluminium complexes of norfloxacin and ciprofloxacin fluoroquinolones. Magn Reson Chem 45:850–859

Chen ZF, Li BQ, Xie YR, Xiong RG, You XZ, Feng XL (2001) Synthesis, crystal structure, and characterization of mixed-ligand complex of copper(I) with drug of norfloxacin and triphenyl phosphine: [Cu(PPh3)2(H-Norf)]ClO4. Inorg Chem Commun 4:346–349

Dimas K, Demetzos C, Marsellos M, Sotiriadou R, Malamas M, Kokkinopoulos D (1998) Cytotoxic activity of labdane type diterpenes against human leukemic cell lines in vitro. Planta Med 64:208–211

Drevenšek P, Košmrlj J, Giester G, Skauge T, Sletten E, Sepčić K, Turel I (2006) X-Ray crystallographic, NMR and antimicrobial activity studies of magnesium complexes of fluoroquinolones–racemic ofloxacin and its S-form, levofloxacin. J Inorg Biochem 100:1755–1763

Efthimiadou EK, Sanakis Y, Raptopoulou CP, Karaliota A, Katsaros N, Psomas G (2006) Crystal structure, spectroscopic, and biological study of the copper(II) complex with third-generation quinolone antibiotic sparfloxacin. Bioorg Med Chem Lett 16:3864–3867

Efthimiadou EK, Psomas G, Sanakis Y, Katsaros N, Karaliota A (2007a) Metal complexes with the quinolone antibacterial agent N-propyl-norfloxacin: Synthesis, structure and bioactivity. J Inorg Biochem 101:525–535

Efthimiadou EK, Sanakis Y, Katsaros N, Karaliota A, Psomas G (2007b) Transition metal complexes with the quinolone antibacterial agent pipemidic acid: synthesis, characterization and biological activity. Polyhedron 26:1148–1158

Gonsette R (1996) Multiple sclerosis. Introductory remarks: immunosuppressive and immunomodulating drugs, where and how do they act? Mult Scler 1:306–312

Helfand SL, Werkmeister J, Roder JC (1982) Chemiluminescence response of human natural killer cells. I. The relationship between target cell binding, chemiluminescence and cytolysis. J Exp Med 156:492–505

Kampranis SC, Maxwell A (1998) The DNA gyrase–quinolone complex. J Biol Chem 273:22615–22626

Lecomte S, Baron MH, Chenon MT, Coupry C, Moreau NJ (1994) Effect of magnesium complexation by fluoroquinolones on their antibacterial properties. Antimicrob Agents Chemother 38:2810–2816

Li Y, Chai Y, Yuan R, Liang W (2008) Synthesis and application of a new copper(II) complex containing oflx and leof. Russ J Inorg Chem 53:704–706

Muhammad I, Javed I, Shahid I, Nazia I (2007) In vitro antibacterial studies of ciprofloxacin-imines and their complexes with Cu(II), Ni(II), Co(II), and Zn(II). Turkish J Biol 31:67–72

Nielsen M, Gerwien J, Geisle C, Ropke C, Svejgaard A, Odum N (1988) MHC class II ligation induces CD58 (LFA-3)-mediated adhesion in human T cells. Exp Clin Immunogenet 15:61–68

Osar Z, Samanci T, Demirel GY, Damci T, Ilkova H (2004) Nicotinamide effects oxidative burst activity of neutrophils in patients with poorly controlled type 2 diabetes mellitus. Exp Diabetes Res 5:155–162

Palumbo M, Gatto B, Zagotto G, Palu G (1993) Opinion on the mechanism of action of quinolone drugs. Trends Microbiol 6:232–235

Petra D, Tatjana Z, Boris P, Jerala R, Kolitsch U, Plaper A, Ture I (2005) Mixed-valence Cu(II)/Cu(I) complex of quinolone ciprofloxacin isolated by a hydrothermal reaction in the presence of l-histidine: comparison of biological activities of various copper-ciprofloxacin compounds. J Inorg Biochem 99:432–442

Ruiz M, Perello L, Cario JS, Ortiz R, Granda SG, Diaz MR, Canton E (1998) Cinoxacin complexes with divalent metal ions. Spectroscopic characterization. Crystal structure of a new dinuclear Cd(II) complex having two chelate-bridging carboxylate groups. J Inorg Biochem 69:231–239

Sagdinc S, Bayar S (2004) Spectroscopic studies on the interaction of ofloxacin with metals. J Mol Struct 691:107–113

Sakai M, Hara A, Anjo S, Nakamura M (1999) Comparison of the complexation of fluoroquinolone antimicrobials with metal ions by nuclear magnetic resonance spectroscopy. J Pharm Biomed Anal 18:1057–1067

Tumer M, Koksal H, Sener MK (1999) Antimicrobial activity studies of the binuclear metal complexes derived from tridentate Schiff base ligand. Transition Met Chem 24:414–420

Turel I (2002) The interactions of metal ions with quinolone antibacterial agents. Coord Chem Rev 232:27–47